From: Research and Nonresearch Industry Payments for COVID-19 mRNA Vaccines in the United States
| Variables | Type of COVID-19 vaccines | Overall | ||
|---|---|---|---|---|
| Pfizer-BioNTech COVID-19 Vaccine | Moderna COVID-19 | |||
| BioNTech | Pfizer | Vaccine | ||
| Overall | ||||
| Total payment amounts, $ (%) | 4,252,074.58 (1.2) | 242,966,738.08 (68.2) | 109,200,692.69 (30.6) | 356,419,505.35 |
| Number of payment recipients, n | 12 physicians | 232 physicians | 175 physicians | 372 physicians |
| 1 teaching hospital | 3 teaching hospitals | 2 nurse practitioners | 2 nurse practitioners | |
| 4 teaching hospitals | ||||
| Research payments | ||||
| Payments amounts, $ (%) | 4,140,488.58 (1.2) | 242,734,243.91 (68.3) | 108,756,027.67 (30.6) | 355,630,760.16 (99.8) |
| Number of payment recipients, n | 12 physicians | 224 physicians | 150 physicians | 340 physicians |
| 2 teaching hospitals | 2 teaching hospitals | |||
| Median payments per recipient (IQR), $ | 198,674.75 | 612,737.36 | 321,262.67 | 550,964.96 |
| (36,380.81-490,409.02) | (94,859.41-1,498,176.54) | (56,720.25-1,153,151.65) | (63,058.98-1,436,790.37) | |
| Nonresearch payments | ||||
| Payment amounts, $ (%) | 111,586 (14.1) | 232,494.17 (29.5) | 444,665.02 (56.4) | 788,745.19 (0.2) |
| Number of payment recipients, n | 1 teaching hospital | 9 physicians | 25 physicians | 34 physicians |
| 3 teaching hospitals | 2 nurse practitioners | 2 nurse practitioners | ||
| 4 teaching hospitals | ||||
| Median payments per recipient (IQR), $ | 7,800 (4,900-50,000)* | 2,100 (1,600-3,575) | 3,350 (1,637.5 7,850) | |
| Nature of payments, $ (%) | ||||
| Consulting | 0 (0) | 113,604.17 (48.9) | 444,613 (100.0) | 558,217.17 (70.8) |
| Royalty and license | 111,586 (100.0) | 100,000 (43.0) | 0 (0) | 211,586 (26.8) |
| Speaking compensation | 0 (0) | 18,890 (8.1) | 0 (0) | 18,890 (2.4) |
| Food and beverage | 0 (0) | 0 (0) | 52.02 (0.01) | 52.02 (0.01) |
